Ectica Technologies is an innovative company based in Zurich-Switzerland developing screening-compatible tools and technologies for ex-vivo tumor-stroma interaction studies. Our objective is to provide industry leaders working in oncology pre-clinical research with pre-developed and well characterized ex-vivo models of the tumor stroma for the subsequent addition of tumor cells. These systems include patient-derived cancer associated fibroblasts (CAFs) matrices for adenocarninoma co-cultures to assess chemoprotection and collective migration. In addition we offer models of the human bone marrow's vascular niche for the ex-vivo maintenance/screening of blood cancer cells. These systems are developed in proprietary 3DProSeed hydrogel plates (imaging well plate format featuring pre-casted, synthetic animal-free and optically clear hydrogels) including matching human cells (incl. patient-derived cells), media and reagents. More info can be found here: https://www.ectica-technologies.com/stromaline
We are Ectica ! Corporate Video!
|Access Date||Quiz Result||Score||Actions|